Fogarty Innovation · Aug 2024
Fogarty says Corveus joined its Company Accelerator Program; the piece describes co-founders Tyler Melton and Ishan Kamat, their Biodesign background, and their path toward first-in-human study and commercialization.
Catheter-based solution to treat chronic heart failure.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Corveus Medical is a Houston-based medical device company in the Texas Medical Center developing a minimally invasive, catheter-based nerve ablation therapy for moderate congestive heart failure. The device targets a sympathetic nerve branch implicated in heart-failure progression and includes real-time confirmation of nerve deactivation.
Primary product
A minimally invasive catheter-based nerve ablation system for congestive heart failure
Founded
2021
Headquarters
Houston, Texas, United States (Texas Medical Center)
Team size
1-10
Industry
Medical Equipment Manufacturing
Sub-industry
Cardiovascular medical devices / catheter-based heart-failure therapy
Offices
0 jobs at Corveus Medical
Check back later for new openings
Business model
Stage
seed
Total raised
$1M
Latest round
Incubator/Accelerator - II · Jul 2023
Jul 2023 · MassChallenge U.S.
Mar 2023 · National Science Foundation
Jun 2022 · MedTech Innovator
Mar 2022 · Y Combinator
Leadership
CEO and Co-Founder
Co-Founder and Chief Medical Officer
VP of Engineering
Mission-driven and clinically focused, with public messaging emphasizing patient impact, precision engineering, collaboration with mentors and accelerators, and a path to commercialization.
Pricing
Not publicly disclosed.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Public third-party estimates conflict; roughly ~$256k to $1M-$10M.
Estimated monthly visits
542
Traffic estimate as of Mar 2026
Fogarty Innovation · Aug 2024
Fogarty says Corveus joined its Company Accelerator Program; the piece describes co-founders Tyler Melton and Ishan Kamat, their Biodesign background, and their path toward first-in-human study and commercialization.
EIN Presswire / Junkosha · Jun 2024
Junkosha named Corveus Medical the category winner in its 2023-2024 Technology Innovator of the Year Award program, highlighting the company’s catheter-based heart-failure device.
Corveus Medical · Jan 2024
Corveus Medical was featured by its own site as a top Y Combinator-backed medical device company for 2024.
Corveus Medical / TMC · Nov 2023
Describes Tyler Melton’s Biodesign journey and states Corveus raised funding after animal studies and later received an NSF SBIR Phase 1 grant and won $35K at Texas A&M New Ventures Competition.
Medsider
Interview summarizes the product, the PMA regulatory strategy, preclinical progress, and Tyler Melton’s founder story.